We thank Drs. Geuna and Tos for their interest in our article, “Comparison of Biodegradable Conduits within Aged Rat Sciatic Nerve Defects” (Plast. Reconstr. Surg. 119: 1839, 2007). We appreciate their important comments. With regard to their two comments (the 3-month endpoint for the rat studies and the use of the Luxol blue myelin stain), we would like to present further justification.
With regard to the endpoint for the rat studies, our rationale for choosing to end the nerve regeneration study at 3 months was as follows: 3 months is a well-accepted endpoint for rat sciatic nerve repair (1.0-cm gap) and is important for gauging the potential for nerve regeneration. We identified more than a dozen publications that utilized the 3-month endpoint for a 1.0-cm gap in the rat sciatic nerve defect.
On the second point, we disagree that Luxol blue is a “rather unusual” stain for nerve repair studies. Indeed, Luxol fast blue is one of the classic stains for myelin, dating back to 1953.1 We identified more than two dozen articles that used Luxol fast blue as a myelin stain, from 1953 to 2007. Due to the Journal’s limits on citations, we herein reference nine key articles.2–10 Although toluidine blue may be more commonly used and is the accepted standard, we believe our choice of Luxol blue for myelin staining was also appropriate and adequate.
Again, we appreciate Drs. Geuna and Tos’s interest and important comments.
Kacey G. Marra, Ph.D.
Julio A. Clavijo-Alvarez, M.D., Ph.D.
Division of Plastic Surgery
University of Pittsburgh
1. Kluver, H., and Barrera, E. A method for the combined staining of cells and fibers in the nervous system. J. Neuropathol. Exp. Neurol.
12: 400, 1953.
2. Odaka, M., Uchiyama, Y., Oka, Y., and Tamaki, T. Evaluation of morphological and functional regeneration of rat nerve-muscle units after temporary and permanent tubulization Muscle Nerve
28: 194, 2003.
3. Yin, D., Wang, X. H., Yan, Y., and Zhang, R. Preliminary studies on peripheral nerve regeneration using a new polyurethane conduit. J. Bioact. Compat. Polym.
22: 143, 2007.
4. Pineros-Fernandez, A., Rodeheaver, P. F., and Rodeheaver, G. T. Octyl 2-cyanoacrylate for repair of peripheral nerve. Ann. Plast. Surg.
55: 188, 2005.
5. Snodgress, A. B., Dorsey, C. H., and Lacey, L. B. Luxol fast blue staining of degenerating myelinated fibers. Anat. Rec.
140: 83, 1961.
6. Watanabe, K., Tsukagoshi, T., Kuroda, M., and Hosaka, Y. Nerve conduit using fascia-wrapped fibrocollagenous tube. J. Reconstr. Microsurg.
17: 363, 2001.
7. Smith, R., Wiedl, C., Chubb, P., and Greene, C. Role of small intestine submucosa (SIS) as a nerve conduit: Preliminary report. J. Invest. Surg.
17: 339, 2004.
8. Rao, P., Kotwal, P., Farooque, M., and Dinda, A. Muscle autografts in nerve gaps: Pattern of regeneration and myelination in various lengths of graft: An experimental study in guinea pigs. J. Orthop. Sci.
6: 527, 2001.
9. Marta, C., Paez, P., Lopez, M., Pellegrino de Iraldi, A., Soto, E., and Pasquini, J. Morphological changes of myelin sheaths in rats intracranially injected with apotransferrin. Neurochem. Res.
28: 101, 2001.
10. Patani, R., Balaratnam, M., Vora, A., and Reynolds, R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol.
33: 277, 2007.
Letters to the Editor, discussing material recently published in the Journal, are welcome. They will have the best chance of acceptance if they are received within 8 weeks of an article’s publication. Letters to the Editor may be published with a response from the authors of the article being discussed. Discussions beyond the initial letter and response will not be published. Letters submitted pertaining to published Discussions of articles will not be printed. Letters to the Editor are not usually peer reviewed, but the Journal may invite replies from the authors of the original publication. All Letters are published at the discretion of the Editor.
Authors will be listed in the order in which they appear in the submission. Letters should be submitted electronically via PRS’ enkwell, at www.editorialmanager.com/prs/.
We reserve the right to edit Letters to meet requirements of space and format. Any financial interests relevant to the content of the correspondence must be disclosed. Submission of a Letter constitutes permission for the American Society of Plastic Surgeons and its licensees and asignees to publish it in the Journal and in any other form or medium.
The views, opinions, and conclusions expressed in the Letters to the Editor represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of the Journal. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.